Citigroup
OLMA icon

Citigroup’s Olema Pharmaceuticals OLMA Stock Holding History

Citigroup’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$607K Sell
70,270
-55,291
-44% -$602K ﹤0.01% 3647
2026
Q2 		$1.57M Buy
125,561
+97,983
+355% +$1.31M ﹤0.01% 3112
2026
Q1 		$411K Sell
27,578
-119,785
-81% -$2.67M ﹤0.01% 3658
2025
Q4 		$3.68M Buy
147,363
+126,917
+621% +$2.26M ﹤0.01% 2231
2025
Q3 		$200K Sell
20,446
-49,885
-71% -$300K ﹤0.01% 3995
2025
Q2 		$300K Buy
70,331
+39,340
+127% +$175K ﹤0.01% 3876
2025
Q1 		$117K Sell
30,991
-37,005
-54% -$186K ﹤0.01% 4511
2024
Q4 		$396K Buy
67,996
+37,899
+126% +$379K ﹤0.01% 3993
2024
Q3 		$359K Buy
30,097
+6,345
+27% +$81.1K ﹤0.01% 3944
2024
Q2 		$257K Sell
23,752
-226,230
-90% -$2.45M ﹤0.01% 3762
2024
Q1 		$2.83M Buy
249,982
+245,175
+5,100% +$3.16M ﹤0.01% 2140
2023
Q4 		$67.4K Buy
4,807
+4,792
+31,947% +$64.4K ﹤0.01% 4384
2023
Q3 		$186 Sell
15
-7,979
-100% -$81.3K ﹤0.01% 5329
2023
Q2 		$72.2K Sell
7,994
-1,918
-19% -$11.6K ﹤0.01% 4413
2023
Q1 		$34.4K Buy
+9,912
New +$40.4K ﹤0.01% 4362
2022
Q4 		– Sell
-1,196
Closed -$3K – 5904
2022
Q3 		$3K Sell
1,196
-466
-28% -$1.98K ﹤0.01% 5401
2022
Q2 		$7K Sell
1,662
-6,317
-79% -$20K ﹤0.01% 5506
2022
Q1 		$34K Sell
7,979
-289
-3% -$1.59K ﹤0.01% 4901
2021
Q4 		$77K Buy
8,268
+5,253
+174% +$109K ﹤0.01% 4862
2021
Q3 		$83K Buy
3,015
+297
+11% +$8.02K ﹤0.01% 4483
2021
Q2 		$76K Buy
2,718
+1,531
+129% +$43.6K ﹤0.01% 4627
2021
Q1 		$39K Sell
1,187
-5,725
-83% -$245K ﹤0.01% 4842
2020
Q4 		$332K Buy
+6,912
New +$324K ﹤0.01% 4577

Other funds holding OLMA

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Citigroup's OLMA Position: Q3 2026 in Review

Citigroup reduced its Olema Pharmaceuticals (OLMA) stake by 44% in Q3 2026, selling an estimated $602K and leaving 70,270 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #3647.

Citigroup first reported a position in OLMA in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.68M in Q4 2025. 43 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Citigroup held 70,270 shares of Olema Pharmaceuticals worth $607K as of Q3 2026.
  • Citigroup sold 55,291 Olema Pharmaceuticals shares in Q3 2026, an estimated $602K.
  • Olema Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3647 holding.
  • Citigroup first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's Olema Pharmaceuticals position peaked at $3.68M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.